ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,417,380 | +21.9% | 362,000 | +18.2% | 4.97% | +20.6% |
| Q2 2023 | $6,084,075 | +19.2% | 306,194 | +2.7% | 4.12% | +9.6% |
| Q1 2023 | $5,104,740 | +0.3% | 298,000 | +14.6% | 3.76% | +20.1% |
| Q4 2022 | $5,088,200 | +363.8% | 260,000 | +1200.0% | 3.13% | +947.2% |
| Q4 2020 | $1,097,000 | -83.3% | 20,000 | -94.3% | 0.30% | -72.1% |
| Q1 2018 | $6,563,000 | – | 350,000 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |